Commercial Viability Offerings

Commercial Viability Review (CVR) is a bespoke engagement where the Council develops a board-ready exit plan and a defined Commercial Viability Roadmap focused on value enhancement

The CVR is a fixed-fee, engagement that typically focuses on the client’s market entry and strategic portfolio alignment.  During the CVR process, we analyze in detail the 7 Domains of Commercial Quotient™ and advise the client on strategy and levers for increasing value across these domains. 

The scope of this engagement includes an assessment of relevant market dynamics and drivers, target vertical applicability, physician workflow considerations, procedural and site-of-service economics, potential barriers to adoption, the competitive landscape for new entrants, and alignment with the portfolios of potential strategic partners or acquirers – all in an interdependent, integrated, and comprehensive fashion.

Our methodology leverages our Commercial Viability Council of subject matter experts, executive leadership team, and proprietary market intelligence across the healthcare value chain, gained through decades of experience at multinational strategic companies and our longstanding relationships throughout the industry.

Our approach combines comprehensive market analysis with real-world validation through direct stakeholder engagement—ensuring recommendations are both strategically sound and practically executable.

Contact Us to Learn More

With certain clients, RQR Advisors partners with the client following the completion of a CVA in a Commercial Viability Partnership(“CVP”), which is a bespoke engagement focused on providing board-level guidance, recommendations, decision making, subject-matter review process, and stakeholder (potential strategic acquirers and investors) introductions and presentations to successfully realize a commercial exit and achieve maximum value.

In addition to ongoing advisement and support with the domains covered in a CVA, the CVP also provides much greater product viability support through all critical stages of the product development and clinical lifecycle. 

The CVP duration typically runs from project inception through a successful commercial outcome. The compensation structure is a combination of cash and equity, with the equity portion designed to further align our interests with the company’s.